Charles Schwab Investment Management Inc. Has $82.31 Million Stock Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Charles Schwab Investment Management Inc. increased its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 0.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,711,280 shares of the real estate investment trust’s stock after purchasing an additional 6,317 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.98% of Sabra Healthcare REIT worth $82,306,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC acquired a new stake in Sabra Healthcare REIT in the first quarter valued at approximately $298,000. New York State Teachers Retirement System grew its stake in Sabra Healthcare REIT by 12.1% in the first quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust’s stock valued at $5,619,000 after acquiring an additional 34,591 shares during the period. M&T Bank Corp grew its stake in Sabra Healthcare REIT by 2.1% in the first quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust’s stock valued at $905,000 after acquiring an additional 1,059 shares during the period. Cambridge Investment Research Advisors Inc. grew its stake in Sabra Healthcare REIT by 4.7% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust’s stock valued at $331,000 after acquiring an additional 853 shares during the period. Finally, Wealth Enhancement Advisory Services LLC acquired a new stake in Sabra Healthcare REIT in the first quarter valued at approximately $180,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on SBRA shares. JMP Securities raised their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th. Scotiabank raised their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research note on Monday, June 23rd. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Sabra Healthcare REIT presently has an average rating of “Moderate Buy” and an average price target of $20.00.

Insider Activity

In related news, Director Michael J. Foster sold 11,000 shares of Sabra Healthcare REIT stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the transaction, the director owned 64,725 shares of the company’s stock, valued at $1,179,289.50. The trade was a 14.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.20% of the stock is currently owned by insiders.

Sabra Healthcare REIT Stock Down 0.5%

Shares of NASDAQ:SBRA opened at $18.53 on Thursday. The stock has a market cap of $4.44 billion, a price-to-earnings ratio of 24.38, a PEG ratio of 1.54 and a beta of 0.86. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The business’s 50 day moving average is $18.31 and its 200 day moving average is $17.59.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. The company had revenue of $189.15 million for the quarter, compared to analysts’ expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. Sabra Healthcare REIT’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.36 earnings per share. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.5%. Sabra Healthcare REIT’s payout ratio is presently 157.89%.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.